Edgewise Therapeutics, Inc. (EWTX)
27.40
+0.80
(+3.03%)
USD |
NASDAQ |
Jan 16, 16:00
27.40
0.00 (0.00%)
After-Hours: 18:36
Edgewise Therapeutics Shareholders Equity (Quarterly): 558.65M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 534.14M |
| Omeros Corp. | -220.48M |
| Gilead Sciences, Inc. | 21.54B |
| Agios Pharmaceuticals, Inc. | 1.284B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 583.47M |
| Total Liabilities (Quarterly) | 24.82M |
| Debt to Equity Ratio | 0.0075 |
| Current Ratio | 26.51 |
| Net Debt Paydown Yield | 0.01% |